Largest biotech in the United States by market cap

Amgen leads the 20 biotech in the United States ranked by market value, at $243.1B, ahead of Gilead Sciences ($209.8B) and Moderna ($81.9B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Amgen$243.1B
Median
$10.6B
Combined market value
$746.3B
Countries
1

Market values as of .

Largest biotech in the United States by market cap
#CompanyMarket cap ↓PriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$243.1B$449.48 1.85% down 34% up United States
2Gilead SciencesGILD · Health Care$209.8B$169.11 0.68% down 33% up United States
3ModernaMRNA · Health Care$81.9B$202.51 2.08% down 755% up United States
4BiogenBIIB · Health Care$37B$250.55 0.10% down 49% up United States
5Revolution MedicinesRVMD · Health Care$34.3B$158.60 2.52% down 131% up United States
6ExelixisEXEL · Health Care$16.7B$68.56 0.09% up 63% up United States
7Neurocrine BiosciencesNBIX · Health Care$16.7B$164.72 0.72% down 20% up United States
8Bio-TechneTECH · Health Care$11.4B$72.73 0.14% up 26% up United States
9Halozyme TherapeuticsHALO · Health Care$10.9B$95.85 0.13% down 37% up United States
10RepligenRGEN · Health Care$10.9B$170.29 5.00% up 5% up United States
11Kymera TherapeuticsKYMR · Health Care$10.4B$121.82 0.25% up 87% up United States
12VaxcytePCVX · Health Care$9.3B$58.75 1.09% down 22% up United States
13Krystal BiotechKRYS · Health Care$9B$303.09 1.52% up 46% up United States
14Twist BioscienceTWST · Health Care$7.7B$113.34 1.20% up 340% up United States
15CG OncologyCGON · Health Care$7B$78.06 1.12% down 85% up United States
16ImmunovantIMVT · Health Care$6.9B$33.34 0.38% up 43% up United States
17ImmunityBioIBRX · Health Care$6.5B$6.15 1.76% down 193% up United States
18Kodiak SciencesKOD · Health Care$6.3B$96.40 0.41% down 396% up United States
19Scholar Rock HoldingSRRK · Health Care$5.7B$47.08 4.43% up 14% up United States
20Adaptive BiotechnologiesADPT · Health Care$4.6B$28.39 0.35% down 88% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration.

Questions and answers

Which biotech in the United States rank first by market value?

Amgen ($243.1B), Gilead Sciences ($209.8B) and Moderna ($81.9B) are the top three of the 20 biotech in the United States ranked by market value as of 18 Nov 2026, 14:51 UTC.

How many biotech in the United States are in this ranking?

20 are ranked by market value.

What are these biotech in the United States worth together?

The 20 biotech in the United States ranked by market value have a combined market value of $746.3B as of 18 Nov 2026, 14:51 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest biotech in the United States by market cap”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states

Underlying data: Yahoo Finance; SEC EDGAR.